Naz Rahman

Stock Analyst at Maxim Group

(0.05)
# 4,810
Out of 5,090 analysts
474
Total ratings
32.7%
Success rate
-11.4%
Average return

Stocks Rated by Naz Rahman

Viking Therapeutics
Oct 30, 2026
Reiterated: Buy
Price Target: $70
Current: $27.28
Upside: +156.60%
Nuvectis Pharma
Oct 26, 2026
Reiterated: Buy
Price Target: $30
Current: $18.48
Upside: +62.34%
Scienture Holdings
Oct 23, 2026
Reiterated: Buy
Price Target: $38 → $6
Current: $3.22
Upside: +86.34%
Clene
Oct 20, 2026
Reiterated: Buy
Price Target: $20
Current: $3.83
Upside: +422.19%
Alpha Cognition
Oct 1, 2026
Reiterated: Buy
Price Target: $12
Current: $8.74
Upside: +37.30%
NEXGEL
Sep 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.51
Upside: -
Aytu BioPharma
Sep 24, 2026
Reiterated: Buy
Price Target: $7
Current: $1.93
Upside: +262.69%
Eocene
Sep 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.10
Upside: -
Quoin Pharmaceuticals
Sep 3, 2026
Reiterated: Buy
Price Target: $16 → $20
Current: $4.54
Upside: +340.53%
Xtant Medical Holdings
Aug 28, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.2802
Upside: +435.33%
Reiterated: Hold
Price Target: n/a
Current: $0.1452
Upside: -
Reiterated: Buy
Price Target: $4
Current: $1.09
Upside: +266.97%
Reiterated: Buy
Price Target: $8
Current: $4.98
Upside: +60.64%
Reiterated: Buy
Price Target: $3
Current: $1.03
Upside: +191.26%
Reiterated: Buy
Price Target: $8
Current: $1.16
Upside: +589.66%
Reiterated: Buy
Price Target: $575
Current: $558.88
Upside: +2.88%
Reiterated: Buy
Price Target: €16.00 → €12.00
Current: €3.03
Upside: +296.30%
Reiterated: Buy
Price Target: $30
Current: $8.50
Upside: +252.94%
Reiterated: Hold
Price Target: n/a
Current: $1.89
Upside: -
Reiterated: Hold
Price Target: n/a
Current: $1.99
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $0.002
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $0.7301
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $3.45
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $4.96
Upside: n/a
Reiterated: Buy
Price Target: $6
Current: $11.41
Upside: n/a